C7ORF28B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.000800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.408600E-01
Normal-vs-Stage2
3.931400E-01
Normal-vs-Stage3
7.285800E-01
Normal-vs-Stage4
6.765400E-01
Stage1-vs-Stage2
5.310400E-01
Stage1-vs-Stage3
3.921400E-01
Stage1-vs-Stage4
9.431400E-01
Stage2-vs-Stage3
5.501200E-01
Stage2-vs-Stage4
5.404800E-01
Stage3-vs-Stage4
5.726400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.045800E-01
Normal-vs-AfricanAmerican
6.985600E-01
Normal-vs-Asian
1.202990E-01
Caucasian-vs-AfricanAmerican
4.759000E-01
Caucasian-vs-Asian
7.512300E-02
AfricanAmerican-vs-Asian
6.176400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.137200E-01
Normal-vs-Female
4.707400E-01
Male-vs-Female
9.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.796400E-01
Normal-vs-Age(41-60Yrs)
4.604400E-03
Normal-vs-Age(61-80Yrs)
2.619400E-01
Normal-vs-Age(81-100Yrs)
9.691200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.205200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.104000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.534400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.535700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.234400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.508200E-01
Normal-vs-Daily Drinker
5.434400E-01
Normal-vs-Weekly Drinker
8.137600E-02
Normal-vs-Occasional Drinker
1.217430E-01
Normal-vs-Social Drinker
9.674100E-02
Non Drinker-vs-Daily Drinker
8.355400E-01
Non Drinker-vs-Weekly Drinker
4.774600E-01
Non Drinker-vs-Occasional Drinker
4.762400E-02
Non Drinker-vs-Social Drinker
4.402200E-02
Daily Drinker-vs-Weekly Drinker
4.358000E-01
Daily Drinker-vs-Occasional Drinker
1.240370E-01
Daily Drinker-vs-Social Drinker
1.172830E-01
Weekly Drinker-vs-Occasional Drinker
2.166000E-02
Weekly Drinker-vs-Social Drinker
1.528010E-02
Occasional Drinker-vs-Social Drinker
9.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.153800E-01
Normal-vs-Grade 2
8.106300E-02
Normal-vs-Grade 3
8.486400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.764000E-02
Grade 1-vs-Grade 3
1.277730E-02
Grade 1-vs-Grade 4
3.153800E-01
Grade 2-vs-Grade 3
1.334240E-01
Grade 2-vs-Grade 4
8.106300E-02
Grade 3-vs-Grade 4
8.486400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.667000E-01
Normal-vs-NonDiabetic
3.727400E-01
Diabetic-vs-NonDiabetic
2.647000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.606100E-02
Normal-vs-NoPancreatitis
6.479400E-01
Pancreatitis-vs-NoPancreatitis
1.804150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.837800E-01
Normal-vs-N1
2.254600E-01
N0-vs-N1
5.272800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.860900E-03
Normal-vs-TP53-NonMutant
3.043400E-01
TP53-Mutant-vs-TP53-NonMutant
4.601600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
